In low-grade glioma (LGG), thymoma (THYM), diffuse large B-cell lymphoma (DLBC) and colon adenocarcinoma (COAD), we identified groups with low ID3 expression which also show a low enrichment score of HR-related pathways (Figure 6G–I, Supplementary Figure S6E–J and S7A–C). This evidence concerns the gene ID3 and thymoma.